Picker bolsters PACS operations
Picker bolsters PACS operationsPicker International has been active in building its Image Management division, adding new staff and reconfiguring its business. Beccie Mendenhall has been promoted to manager of a newly created solutions group,
Picker bolsters PACS operations
Picker International has been active in building its Image Management division, adding new staff and reconfiguring its business. Beccie Mendenhall has been promoted to manager of a newly created solutions group, which has been formed to manage customer projects and provide professional services to customers. Picker has also hired Robert Crawford to lead the firms integration services group, which will support Picker/third party integration assoc- iated with DICOM, for both Pickers PACS and modality businesses. Crawford comes to Picker from Agfa, where he led a similar group.
In other moves, Steve House has been promoted to global sales manager. House has been with Picker for the past 18 months, and previously served as a regional sales manager for Cemax-Icon.
Tom Pacenta continues as marketing manager, while Dr. Tim Cramer has taken on responsibility for Pickers solutions, integration services, and marketing organizations. Cramer also retains his previous role as medical director for the Image Management group and director of corporate connectivity for Picker.
The Cleveland, OH-based firm has also hired two new sales specialists. Jonathan Sharf joins Picker from Merge Technologies, and has also served as a sales representative at Imation. Greg Olivieri, who joins the company from Swissray, was formerly the educational director of the Staten Island University Hospital School of Radiological Sciences.
- Search again
- Homepage
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
